Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sévérine Guiu"'
Autor:
Lucy Meunier, Eleonora De Martin, Bénédicte Delire, Wiliam Jacot, Severine Guiu, Amel Zahhaf, Dominique Larrey, Yves Horsmans
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101098- (2024)
Background & Aims: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are the cornerstone of systemic therapy for patients with hormone receptor-positive, HER2-negative (HR+/HER2-) metastatic breast cancer. In the various therapeutic studies with CDK4/6
Externí odkaz:
https://doaj.org/article/5287791d88734128bdea6c13d1b86939
Autor:
Thomas Bardol, Zahra Eslami‐S, Doryan Masmoudi, Marie Alexandre, Marie Duboys de Labarre, Angélique Bobrie, Véronique D'Hondt, Séverine Guiu, Keerthi Kurma, Laure Cayrefourcq, William Jacot, Catherine Alix‐Panabières
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background For several years, the AXL tyrosine kinase receptor, a member of the Tyro3‐Axl‐Mer (TAM) family, has been considered a new strategic target in oncology. AXL overexpression is common in solid tumors and is associated with poor
Externí odkaz:
https://doaj.org/article/ccb520c1af084716bac58d6380522524
Autor:
Sophie Marilier, Pegdwende Olivia Dialla, Ariane Darut-Jouve, Thierry Altwegg, Patrick Roignot, Tienhan Sandrine Dabakuyo-Yonli, Valérie Quipourt, Patrick Arveux, Sévérine Guiu, Julie Gentil, Marie-Laure Poillot
Publikováno v:
Geriatrics & Gerontology International. 15:617-626
Aim The present study aimed to describe treatments, relative survival and prognostic factors in breast cancer patients according to age. Methods All women with primary invasive breast cancer, diagnosed from 1998 to 2009 in the department of Cote d'Or
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antoine Vasseur, Matthieu Carton, Severine Guiu, Paule Augereau, Lionel Uwer, Marie-Ange Mouret-Reynier, Christelle Levy, Jean-Christophe Eymard, Jean-Marc Ferrero, Marianne Leheurteur, Anthony Goncalves, Marie Robert, Thibault De La Motte Rouge, Thomas Bachelot, Thierry Petit, Marc Debled, Thomas Grinda, Isabelle Desmoulins, Laurence Vanlemmens, Vincent Nicolaï, Gaëtane Simon, Luc Cabel
Publikováno v:
Breast, Vol 65, Iss , Pp 136-144 (2022)
Background: Taxanes are one of the most effective chemotherapies (CT) in breast cancer (BC), but the efficacy of taxanes rechallenge in early metastatic relapse has been poorly studied in patients previously treated by taxanes in the (neo)adjuvant se
Externí odkaz:
https://doaj.org/article/3e5e3d1b6d254f9091fd5376422aa2e4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michel Fabbro, William Jacot, Marta Jarlier, Séverine Guiu, Véronique D'Hondt, Stéphane Pouderoux, Patrice Champoiral, Chloé Janiszewski, Isabelle Nicklès
Publikováno v:
Cancer Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background Acceptability and tolerance of chemotherapy on patients treated for breast cancer remain challenging. Complementary approaches such as hypnosis may have a favorable impact both at the time of announcing and during chemotherapy, du
Externí odkaz:
https://doaj.org/article/65ea6d27b177440db048c732080db422
Autor:
Pegdwende Olivia, Dialla, Valérie, Quipourt, Julie, Gentil, Sophie, Marilier, Marie-Laure, Poillot, Patrick, Roignot, Thierry, Altwegg, Ariane, Darut-Jouve, Sévérine, Guiu, Patrick, Arveux, Tienhan Sandrine, Dabakuyo-Yonli
Publikováno v:
Geriatricsgerontology international. 15(5)
The present study aimed to describe treatments, relative survival and prognostic factors in breast cancer patients according to age.All women with primary invasive breast cancer, diagnosed from 1998 to 2009 in the department of Côte d'Or, were retro
Autor:
Florence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, Séverine Guiu, Angélique Bobrie, William Jacot
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundT cell immunoreceptor with Ig and ITIM domains (TIGIT) interacts with poliovirus receptor (PVR) to contribute to cancer immune escape. Recently, TIGIT and PVR have been identified as promising immunotherapy targets. Their gene expression is
Externí odkaz:
https://doaj.org/article/132cc83966eb4a94bf18c7d1697ca996
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.